Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.

Abstract

New-onset diabetes mellitus as a complication following transplantation has been previously reported by several workers.1–4 However, the role of ethnicity as a factor has not been well defined, particularly with the newer immunosuppressive agents.4,5 In an attempt to understand the nature of this problem in the African American population, we retrospectively studied a group of African Americans who received renal allografts under FK 506 immunosuppression at the University of Pittsburgh Medical Center between October 26, 1989, and July 24, 1992.